+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

AVERT [The Atorvastatin versus Revascularization Treatment]



AVERT [The Atorvastatin versus Revascularization Treatment]



Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl. 3): 436-441




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045135879

Download citation: RISBibTeXText

PMID: 11347110


Related references

Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial. Canadian Journal of Cardiology 16 Suppl A: 11a-13a, 2000

Atorvastatin versus revascularization treatment (AVERT): fact or fancy?. American Heart Journal 140(1): 6-9, 2000

Implications of the atorvastatin versus revascularization treatment (AVERT) study for the clinician. Current Cardiology Reports 2(5): 433-438, 2000

AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering. Zeitschrift für Kardiologie 88(3 Suppl.): 1-4, 1999

Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. European Heart Journal 21(13): 1029-1031, 2000

Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. European Heart Journal 22(11): 972-973, 2001

Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with atorvastatin versus revascularization treatments (AVERT). American Journal of Cardiology 80(9): 1130-1133, 1997

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. New England Journal of Medicine 341(2): 70-76, 1999

Results of the Atorvastatin VErsus Revascularization Treatments study An 18-month study of aggressive lipid lowering in patients with stable coronary artery disease indicated for a catheter-based revascularization. Circulation 98(17 Suppl. ): I636, 1998

The benefit of aggressive lipid lowering Atorvastatin Versus Revascularization Treatments. European Heart Journal 20(ABSTR Suppl. ): 607, 1999

Can aggressive lipid-lowering therapy provide additional clinical benefit? Subgroup analysis of the Atorvastatin VErsus Revascularization Treatments trial. European Heart Journal 21(Abstract Suppl.): 157, August-September, 2000

Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack. Revista de Neurologia 62(5): 203-210, 2016

Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). American Journal of Cardiology 102(10): 1312-1317, 2008

Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g). American Journal of Cardiology 102(10): 1341-1347, 2008

Clinical trials of coronary revascularization for chronic stable angina: medical treatment versus coronary revascularization. Current Opinion in Cardiology 15(4): 275-280, 2000